VIAPIANA, Ombretta
 Distribuzione geografica
Continente #
EU - Europa 13.403
NA - Nord America 10.676
AS - Asia 8.247
SA - Sud America 1.187
AF - Africa 176
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 33.718
Nazione #
US - Stati Uniti d'America 10.455
RU - Federazione Russa 5.142
SG - Singapore 3.361
GB - Regno Unito 2.969
CN - Cina 2.729
IT - Italia 1.446
BR - Brasile 964
DE - Germania 881
HK - Hong Kong 746
SE - Svezia 711
FR - Francia 650
IE - Irlanda 598
VN - Vietnam 526
FI - Finlandia 411
KR - Corea 180
IN - India 160
UA - Ucraina 145
JP - Giappone 141
CA - Canada 119
TR - Turchia 114
PL - Polonia 89
AR - Argentina 77
MX - Messico 72
NL - Olanda 69
ES - Italia 63
BD - Bangladesh 61
ID - Indonesia 55
AT - Austria 52
ZA - Sudafrica 48
BE - Belgio 44
EC - Ecuador 39
BJ - Benin 36
VE - Venezuela 29
IQ - Iraq 28
CO - Colombia 22
RO - Romania 22
TG - Togo 20
UZ - Uzbekistan 19
CL - Cile 18
IR - Iran 18
EG - Egitto 17
PK - Pakistan 16
AU - Australia 14
CH - Svizzera 14
LT - Lituania 14
PE - Perù 14
AE - Emirati Arabi Uniti 13
MA - Marocco 13
PY - Paraguay 10
AL - Albania 9
AZ - Azerbaigian 8
DZ - Algeria 8
IL - Israele 8
KE - Kenya 8
SA - Arabia Saudita 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
GR - Grecia 7
CR - Costa Rica 6
NP - Nepal 6
PT - Portogallo 6
SN - Senegal 6
UY - Uruguay 6
AM - Armenia 5
BG - Bulgaria 5
DK - Danimarca 5
HU - Ungheria 5
JO - Giordania 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
EU - Europa 4
GE - Georgia 4
HR - Croazia 4
JM - Giamaica 4
KG - Kirghizistan 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
HN - Honduras 3
KW - Kuwait 3
MK - Macedonia 3
SI - Slovenia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BW - Botswana 2
LB - Libano 2
LK - Sri Lanka 2
ME - Montenegro 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
Totale 33.681
Città #
Southend 2.632
Moscow 1.754
Singapore 1.642
Chandler 1.335
Dallas 1.223
Ashburn 931
Jacksonville 883
Hong Kong 742
Dublin 595
Beijing 478
Ann Arbor 475
Woodbridge 465
Houston 302
New York 283
Los Angeles 255
Lawrence 234
Princeton 234
Wilmington 232
Jinan 224
The Dalles 207
Redmond 194
Bologna 187
Nanjing 173
Shenyang 172
Ho Chi Minh City 170
Verona 161
Munich 143
Helsinki 127
Tokyo 126
Buffalo 113
Hanoi 108
Hebei 104
Milan 104
Redondo Beach 102
Tianjin 101
São Paulo 95
Sindelfingen 85
Warsaw 77
Changsha 75
Zhengzhou 72
Ningbo 68
Haikou 67
London 67
Santa Clara 66
Columbus 65
Denver 59
Nanchang 58
Taizhou 58
Redwood City 54
Guangzhou 53
Hangzhou 52
Brooklyn 51
Falkenstein 50
Seattle 50
Jiaxing 48
Turku 45
Orem 44
Taiyuan 44
Rome 43
Brussels 42
San Francisco 42
Montreal 39
Hyderabad 37
Chicago 36
Cotonou 36
Norwalk 35
Toronto 35
Washington 35
Boardman 34
Poplar 34
Johannesburg 33
Phoenix 33
Vienna 33
Boston 31
Mexico City 31
Atlanta 30
Fuzhou 30
Manchester 29
Brasília 28
Chennai 28
Düsseldorf 27
Fairfield 27
Rio de Janeiro 27
Stockholm 27
Lanzhou 26
Dong Ket 25
Da Nang 24
Jakarta 24
Falls Church 23
Dearborn 22
Torino 22
Lancaster 21
Lomé 20
Ankara 19
Belo Horizonte 18
Campinas 18
Detroit 18
Seoul 18
Tashkent 18
Amsterdam 17
Totale 19.809
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 660
Teriparatide and denosumab combination therapy and skeletal metabolism 313
Artrite Reumatoide e Metabolismo Minerale 246
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 242
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 229
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 226
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 222
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 212
Anti-CCP antibodies and bone 209
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 202
Bone metabolism in patients with anorexia nervosa and amenorrhoea 198
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 196
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 195
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 194
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 194
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 193
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 190
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 188
[Risk factors for hip fracture in elderly persons]. 188
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 187
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 184
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 182
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 181
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 180
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 180
Bone involvement and osteoporosis in mastocytosis. 176
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 176
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 175
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 173
Could γ\δ T-cells explain zoledronic acid adverse events? 169
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 169
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 169
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 168
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 167
[Pathophysiology of osteoarthritis: perspectives] 166
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 166
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 165
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 165
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 161
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 161
Allergy and the bone: unexpected relationships 160
Prevalence and incidence of rheumatoid arthritis in Italy. 160
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 160
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 159
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 159
Guidelines for the diagnosis, prevention and management of osteoporosis 159
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 157
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 157
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 154
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 152
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 151
DXA bone mineral density in males: retrospective study in real life. 150
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 149
Artropatie degenerative 148
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 148
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 148
Bone Disease in Mastocytosis 148
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 148
Effects of denosumab on peripheral lymphocyte subpopulations 148
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 148
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 146
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 146
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 146
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 145
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 144
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 144
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 144
Prevalence of osteoporosis in patients affected by mastocytosis 143
Safety issues and adverse reactions with osteoporosis management 141
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 141
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 140
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 140
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 140
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 139
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 138
Sclerostin and DKK1 in primary hyperparathyroidism. 137
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 137
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 137
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 137
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 136
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 136
Association between environmental air pollution and rheumatoid arthritis flares 136
Osteopetrosi 135
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 135
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 135
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 134
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 134
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 133
Bone turnover markers in patients with osteogenesis imperfecta. 132
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 132
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 132
Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis 132
Focal bone involvement in inflammatory arthritis: the role of IL17 131
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 130
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 130
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 130
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 129
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 129
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 128
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 128
Totale 16.642
Categoria #
all - tutte 116.619
article - articoli 111.683
book - libri 0
conference - conferenze 597
curatela - curatele 0
other - altro 1.290
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.049
Totale 233.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 0 207 74 96 165 15 202 101
2021/20221.908 127 520 29 110 88 55 59 107 145 48 143 477
2022/20234.026 282 380 382 709 332 966 51 224 461 59 129 51
2023/20242.170 111 163 193 264 238 344 103 171 28 92 318 145
2024/20255.346 286 344 259 800 248 166 220 210 789 419 529 1.076
2025/202611.991 1.202 888 1.302 3.039 4.525 1.035 0 0 0 0 0 0
Totale 34.243